Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F BENDER

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Scientific Monthly|October 29, 2010
Do you know a dyslexiac?J F BENDER
The Scientific Monthly|March 19, 2010
Aptitude testingJ F BENDER
Clinics in Podiatric Medicine and Surgery|January 1, 1996
Tinea pedis: diagnosis and treatmentK E Brooks, J F Bender
Investigational New Drugs|April 9, 2001
Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignanciesR R Streiff, J F Bender
American Journal of Hospital Pharmacy|September 1, 1977
High-dose methotrexate with folinic acid rescueJ F Bender, W R Grove, C L Fortner
Investigational New Drugs|January 1, 1983
Diaziquone (AZQ)J F Bender, A J Grillo-Lopez, J G Posada
Investigational New Drugs|January 1, 1985
A phase I trial of ametantrone acetate (NSC-287513)R A Gams, F Ostroy, J F Bender, et al.
Cancer Treatment Reports|February 1, 1985
Phase II trial of diaziquone in patients with colon cancerJ A Neidhart, C Erlichman, F Robert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
A phase II trial of diaziquone in patients with head and neck cancerF Muñiz, E Vélez-García, J A Neidhart, et al.
American Journal of Hospital Pharmacy|August 1, 1979
Comparative auditory toxicity of aminoglycoside antibiotics in leukopenic patientsJ F Bender, C L Fortner, S C Schimpff, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Scientific Monthly|October 29, 2010
Do you know a dyslexiac?J F BENDER
The Scientific Monthly|March 19, 2010
Aptitude testingJ F BENDER
Clinics in Podiatric Medicine and Surgery|January 1, 1996
Tinea pedis: diagnosis and treatmentK E Brooks, J F Bender
Investigational New Drugs|April 9, 2001
Phase 1 study of N1-N11-diethylnorspermine (DENSPM) administered TID for 6 days in patients with advanced malignanciesR R Streiff, J F Bender
American Journal of Hospital Pharmacy|September 1, 1977
High-dose methotrexate with folinic acid rescueJ F Bender, W R Grove, C L Fortner
Investigational New Drugs|January 1, 1983
Diaziquone (AZQ)J F Bender, A J Grillo-Lopez, J G Posada
Investigational New Drugs|January 1, 1985
A phase I trial of ametantrone acetate (NSC-287513)R A Gams, F Ostroy, J F Bender, et al.
Cancer Treatment Reports|February 1, 1985
Phase II trial of diaziquone in patients with colon cancerJ A Neidhart, C Erlichman, F Robert, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1987
A phase II trial of diaziquone in patients with head and neck cancerF Muñiz, E Vélez-García, J A Neidhart, et al.
American Journal of Hospital Pharmacy|August 1, 1979
Comparative auditory toxicity of aminoglycoside antibiotics in leukopenic patientsJ F Bender, C L Fortner, S C Schimpff, et al.
Pageof 2